Skip to content

Trial Summary

Registry-based Study of Enzalutamide vs Abiraterone assessing cognitive function in Elderly Metastatic Castration-Resistant Prostate Cancer



ACTRN/NCT /ethics:


Scientific title:

A prospective, open-label, multi-centre, registry-based randomised clinical trial comparing the cognitive impact of standard-of-care treatments in men aged 75 years or older that have metastatic castration-resistant prostate cancer.

Sponsor / Cooperative group:

Walter & Eliza Hall Institute

Trial & Patient Characteristics

Cancer TypeProstate
Trial TypeTreatment
PhasePhase IV
Age Range75 years and older
Tumour Stream Prostate
Cancer StageMetastatic or Widespread
Anticipated Start Date2019-06-12
Anticipated End Date2022-04-26

Participating Hospitals

HospitalIcon Cancer Centre Adelaide
Clinical Trial CoordinatorSue Yeend
Phone08 8292 2204
Principal InvestigatorDr Francis Parnis
Recruitment StatusRecruiting
HospitalFlinders Medical Centre
Clinical Trial CoordinatorHannah Adelson
Phone08 8206 4835
Principal Investigator-
Recruitment StatusRecruiting